# Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response

> **NCT03701061** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 12 (actual)

## Conditions studied

- Influenza A Subtype H5N1 Infection

## Interventions

- **BIOLOGICAL:** Seasonal Influenza Vaccine
- **BIOLOGICAL:** Seasonal Influenza Vaccine

## Key facts

- **NCT ID:** NCT03701061
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-11
- **Primary completion:** 2019-02-28
- **Final completion:** 2020-01-31
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03701061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03701061, "Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03701061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*